Nasdaq:US$16.62 (-1.04) | HKEX:HK$26.65 (-1.55) | AIM:£2.68 (-0.19)
News & Presentations
Previous Article   |   Next Article
Presentations, Scientific Publications | 27 Sep 2015

ESMO 2015: Phase II trial of fruquintinib in metastatic colorectal cancer

1 items
View PDF